- UroToday Home
- Recent Abstracts
- Urologic Oncology
CRPC w/ Bone Metastases
Neuronal calcitonin gene-related peptide promotes prostate tumor growth in the bone microenvironment.
October 22, 2020
FOXA2 promotes prostate cancer growth in the bone.
October 14, 2020
The botanical component p-hydroxycinnamic acid suppresses the growth and bone metastatic activity of human prostate cancer PC-3 cells in vitro.
October 2, 2020
Differential expression of NKX 3.1 and HOXB 13 in bone metastases originating from prostatic carcinoma among the Egyptian males.
September 30, 2020
Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT.
September 28, 2020
Prostate cancer-derived MMP-3 controls intrinsic cell growth and extrinsic angiogenesis.
September 11, 2020
Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center.
September 10, 2020
Antiresorptive agent-related osteonecrosis of the jaw in prostate cancer patients with bone metastasis treated with bone-modifying agents.
September 8, 2020
Clinical indicators for predicting prognosis after radium-223 administration in castration-resistant prostate cancer with bone metastases.
September 4, 2020
Differentiation of bone metastases from prostate cancer and benign red marrow depositions of the pelvic bone with multiparametric MRI.
August 31, 2020
Development of Convolutional Neural Networks to identify bone metastasis for prostate cancer patients in bone scintigraphy.
August 27, 2020